home / stock / amgn / amgn articles

AMGN Articles, Amgen Inc. - From 05/03/24

Stock Information
Company Name: Amgen Inc.
Stock Symbol: AMGN
Market: NASDAQ
Website: amgen.com
Menu
AMGN AMGN Quote AMGN Short AMGN News AMGN Articles AMGN Message Board
Get AMGN Alerts

News, Short Squeeze, Breakout and More Instantly...
Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars Today | Benzinga

Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66, while the S&am...
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment | Benzinga

Amgen Inc. (NASDAQ:AMGN) reported first-quarter financial results after the closing bell Thursday. Here's a look at the highlights. The Detai...

Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market | Benzinga

U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index future...

What's Going On With CytomX Stock? | Benzinga

CytomX Therapeutics, Inc. (NASDAQ:CTMX) shares are racing higher Wednesday. The company said it will report first-quarter results and provide an in...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab | Benzinga

Generic and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on Tuesday with Amgen Inc&...

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week | Benzinga

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? | Benzinga

A recent academic case study, published on April 22, examined using Amgen Inc’s (NASDAQ:AMGN) Blincyto, a bispecific CD3x...
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick | Benzinga

Tuesday, Amgen Inc (NASDAQ:AMGN) provided an update regarding the results of the Phase 2a COURSE trial for Tezspire (tezepelumab-ekko) in...

Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Amgen, Shell And More On CNBC's 'Final Trades' | Benzinga

On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) has 12% free cash flow yield...
Previous 10 Next 10